The Idyeas Group

De-Risking Health & Biotech Investments Through Strategic Non-Dilutive Funding We partner with investors to strengthen and scale portfolio companies in health and biotech by unlocking non-dilutive capital and aligning ventures with federal and mission-driven funding streams. Our approach helps de-risk early-stage investments, extend runway, and accelerate commercial and clinical milestones—particularly for startups addressing critical gaps in digital health and underserved markets. From Lab to Launch: Strategic Funding for Health & Biotech Founders We specialize in helping startups and small businesses access strategic, non-dilutive funding to scale innovative health solutions—especially in underserved markets. Our expertise spans grant strategy, federal partnerships, and ecosystem navigation—empowering founders to focus on science while we handle the funding roadmap. From early discovery to clinical validation, we also support team capacity building and connect companies to public-private resources that amplify investor readiness and long-term impact. We would love to connect with you!